Injectable Coacervate Hydrogel for Delivery of Anticancer Drug-Loaded Nanoparticles in vivo
Source abstract
Abstract
In this study, bortezomib (BTZ, a cytotoxic water-insoluble anticancer drug) was encapsulated in micellar nanoparticles having a catechol-functionalized polycarbonate core through a pH-sensitive covalent bond between phenylboronic acid (PBA) in BTZ and catechol, and these drug-loaded micelles were incorporated into hydrogels to form micelle/hydrogel composites. A series of injectable, biodegradable hydrogels with readily tunable mechanical properties were formed and optimized for sustained delivery of the BTZ-loaded micelles through ionic coacervation between PBA-functionalized polycarbonate/poly(ethylene glycol) (PEG) "ABA" triblock copolymer and a cationic one having guanidinium- or thiouronium-functionalized polycarbonate as "A" block. An in vitro release study showed the pH dependence in BTZ release. At pH 7.4, the BTZ release from the micelle/hydrogel composite remained low at 7%, whereas in an acidic environment, ∼85% of BTZ was released gradually over 9 days. In vivo studies performed in a multiple myeloma MM.1S xenograft mouse model showed that the tumor progression of mice treated with BTZ-loaded micelle solution was similar to that of the control group, whereas those treated with the BTZ-loaded micelle/hydrogel composite resulted in significant delay in the tumor progression. The results demonstrate that this hydrogel has great potential for use in subcutaneous and sustained delivery of drug-loaded micelles with superior therapeutic efficacy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Hydrogels: synthesis, properties, applications · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Bioengineering and Nanotechnology, 31 Biopolis Way, Singapore 138669, Singapore
IBM Almaden Research Center, 650 Harry Road, San Jose, California 95120, United States
Funding
International Business Machines Corporation · Institute of Bioengineering and Nanotechnology, Agency for Science, Technology and Research
References (42)
Show source-provided references
1. 10.2174/15680091179451975210.2174/156800911794519752 ↗
2. 10.1016/j.jconrel.2014.12.04310.1016/j.jconrel.2014.12.043 ↗
3. 10.1158/1078-0432.ccr-09-329310.1158/1078-0432.ccr-09-3293 ↗
4. Taylor J. · 2018 · 5
5. 10.1056/nejmoa03028810.1056/nejmoa030288 ↗
6. 10.1073/pnas.140133711110.1073/pnas.1401337111 ↗
7. 10.1016/j.jconrel.2014.12.04310.1016/j.jconrel.2014.12.043 ↗
8. 10.1016/j.nantod.2012.08.00510.1016/j.nantod.2012.08.005 ↗
9. 10.1002/marc.20100060010.1002/marc.201000600 ↗
10. Stella V. · 200710.1007/978-0-387-49785-3 ↗
11. 10.1016/j.biomaterials.2009.01.00610.1016/j.biomaterials.2009.01.006 ↗
12. 10.1021/acsami.5b0745610.1021/acsami.5b07456 ↗
13. 10.1016/j.bios.2008.10.01410.1016/j.bios.2008.10.014 ↗
14. 10.1002/chem.20070191110.1002/chem.200701911 ↗
15. 10.1021/bm034139o10.1021/bm034139o ↗
16. 10.1021/ma035382i10.1021/ma035382i ↗
17. 10.1021/ja982975d10.1021/ja982975d ↗
18. 10.1021/bm034541310.1021/bm0345413 ↗
19. 10.1016/0168-3659(95)00084-410.1016/0168-3659(95)00084-4 ↗
20. 10.1016/j.polymer.2010.04.01110.1016/j.polymer.2010.04.011 ↗
21. 10.1039/c2jm33413e10.1039/c2jm33413e ↗
22. 10.1002/anie.20110625210.1002/anie.201106252 ↗
23. 10.1016/0142-9612(94)90261-510.1016/0142-9612(94)90261-5 ↗
24. 10.1016/j.polymer.2011.07.05710.1016/j.polymer.2011.07.057 ↗
25. 10.4161/cam.2.3.648410.4161/cam.2.3.6484 ↗
26. 10.1039/c4ra01812e10.1039/c4ra01812e ↗
27. 10.1016/j.cocis.2005.04.00410.1016/j.cocis.2005.04.004 ↗
28. 10.1021/ma302299r10.1021/ma302299r ↗
29. 10.1002/adma.20100423010.1002/adma.201004230 ↗
30. 10.1039/b713925j10.1039/b713925j ↗
31. 10.1021/acs.biomac.5b0035910.1021/acs.biomac.5b00359 ↗
32. 10.1021/acs.biomac.7b0037710.1021/acs.biomac.7b00377 ↗
33. 10.1016/j.actbio.2016.09.03610.1016/j.actbio.2016.09.036 ↗
34. 10.1002/adhm.20170138810.1002/adhm.201701388 ↗
35. 10.1016/j.biomaterials.2011.11.03210.1016/j.biomaterials.2011.11.032 ↗
36. 10.1002/adfm.20130130710.1002/adfm.201301307 ↗
37. 10.1021/bm501520610.1021/bm5015206 ↗
38. 10.1016/j.biopha.2014.04.00310.1016/j.biopha.2014.04.003 ↗
39. 10.1016/s0168-3659(00)00280-710.1016/s0168-3659(00)00280-7 ↗
40. Aguilera J. M. · 1999
41. 10.1021/mz500594m10.1021/mz500594m ↗
42. 10.1002/ange.20110714410.1002/ange.201107144 ↗